Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurology

• Publication date

  2011-10-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e318232de76PMID 21956725PMCID PMC12477877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medical management of Lennox-Gastaut syndrome

  2010cited by this paper
• Treatment of Lennox-Gastaut syndrome.

  2009cited by this paper
• Clobazam in the treatment of Lennox‐Gastaut syndrome

  2009cited by this paper
• Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome

  2008cited by this paper
• Benzodiazepines in epilepsy: pharmacology and pharmacokinetics

  2008cited by this paper
• Clobazam as Add-on Therapy in Children with Epileptic Encephalopathy

  2006cited by this paper
• Clobazam as a New Antiepileptic Drug and Clorazepate Dipotassium as an Alternative Antiepileptic Drug in Japan

  2004cited by this paper
• Clobazam monotherapy in drug naïve adult patients with epilepsy.

  2003cited by this paper
• Treatment of Lennox-Gastaut syndrome.

  2003cited by this paper
• 抗てんかん薬クロバザム(マイスタン^ )の薬効薬理

  2001cited by this paper
• [A pharmacological profile of clobazam (Mystan), a new antiepileptic drug].

  2001cited by this paper
• Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

  2000cited by this paper
• Clobazam for the treatment of intractable childhood epilepsy.

  2000cited by this paper
• A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.

  1999cited by this paper
• A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome

  1999cited by this paper
• The Use of Clobazam, Midazolam, and Nitrazepam in Epilepsy

  1998cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome.

  1997cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.

  1997cited by this paper
• Clobazam in Long‐Term Epilepsy Treatment: Sustained Responders Versus Those Developing Tolerance

  1995cited by this paper
• Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

  1993cited by this paper
• Clobazam in Treatment of Refractory Epilepsy: The Canadian Experience. A Retrospecti

  1991cited by this paper
• Clobazam in Therapy‐Resistant Patients with Partial Epilepsy: A Double‐Blind Placebo‐Controlled Crossover Study

  1987cited by this paper
• The Lennox-Gastaut Syndrome and Its Frontiers

  1986cited by this paper
• Clobazam as adjunctive treatment in refractory epilepsy.

  1983cited by this paper
• Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures

  1981cited by this paper
• Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man

  1979cited by this paper
• Treatment of Infantile Spasms and Lennox‐Gastaut Syndrome with Clonazepam (Rivotril®)

  1973cited by this paper

• Stiripentol: Unpublished results from the first phase 2 clinical trial in Lennox-Gastaut syndrome conducted in the early 1990s.

  2026cites this paper
• Treatment of pediatric epilepsy

  2026cites this paper
• History of lennox-gastaut syndrome: Sixty years of advancements in therapeutic practices.

  2025cites this paper
• Efficacy and safety of cenobamate in developmental and epileptic encephalopathies: A systematic review and meta-analysis.

  2025cites this paper
• Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study.

  2025cites this paper
• Efficacy and safety of cannabidiol in children with developmental and epileptic encephalopathies: A systematic review.

  2025cites this paper
• Epileptic drop attacks: More than just atonic seizures.

  2025cites this paper
• Which are the options and dosages for clobazam shortages on epilepsy treatment? Review of literature and survey of specialists

  2025cites this paper
• Efficacy, safety and tolerability of adjunctive cenobamate in pediatric and adult patients with Lennox Gastaut Syndrome.

  2025cites this paper
• Dravet syndrome: novel insights into SCN1A-mediated epileptic neurodevelopmental disorders within the molecular diagnostic-therapeutic framework

  2025cites this paper
• Current and emerging pharmacotherapies in Lennox-Gastaut syndrome

  2025influential citation
• Cannabidiol and microRNAs: shared cellular targets and new insights for developing anti-seizure modalities.

  2025cites this paper
• Increased seizure frequency graphs in medication trials: FDA labels vs. peer-review.

  2025cites this paper
• Seizure-type-specific treatment responses in Lennox-Gastaut Syndrome: A comprehensive review of pharmacological, neuromodulatory, dietary, and surgical therapies.

  2025cites this paper
• Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm.

  2025cites this paper
• Efficacy and safety of pharmacological and non-pharmacological therapies in Lennox-Gastaut syndrome: a systematic review and network meta-analysis

  2025influential citation
• Safety and efficacy of vigabatrin add on compared to placebo in Lennox-Gastaut syndrome (LennoVig): A single center randomized double-blind placebo-controlled trial.

  2025cites this paper
• Nonsedating anxiolytics.

  2024cites this paper
• Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches

  2024cites this paper
• Evaluating the patient needs and tolerability of Clobazam liquid formulation (Likozam® 1 mg/mL): A French patient and care-givers' centered survey.

  2024cites this paper
• Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China

  2024influential citation
• Efficacy and safety of perampanel in patients with seizures associated with Lennox–Gastaut syndrome: A randomized trial

  2024cites this paper
• Antiseizure medication-induced hypersensitivity reactions: Data from a large healthcare system.

  2024cites this paper
• Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis

  2023cites this paper
• Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy

  2023cites this paper
• Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy

  2023cites this paper
• Lennox-Gastaut Syndrome: Current Treatments, Novel Therapeutics, and Future Directions

  2023cites this paper
• Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.

  2023cites this paper
• Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome

  2023cites this paper
• Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports

  2023cites this paper
• Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy

  2023cites this paper
• The burden of illness in Lennox–Gastaut syndrome: a systematic literature review

  2023cites this paper
• Pharmacovigilance on cannabidiol as an antiepileptic agent

  2023cites this paper
• Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome

  2022cites this paper
• Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies

  2022cites this paper
• Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.

  2022cites this paper
• A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)

  2022cites this paper
• The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study.

  2022cites this paper
• Impact of Antiseizure Medications on Appetite and Weight in Children

  2022cites this paper
• Macroglossia Associated With Clobazam Administration: A Case Report and Literature Review

  2022cites this paper
• Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis.

  2022cites this paper
• A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication

  2022influential citation
• Proposal for an updated seizure classification framework in clinical trials

  2022cites this paper
• Anti-seizure medications for Lennox-Gastaut syndrome.

  2021cites this paper
• Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

  2021cites this paper
• CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up

  2021cites this paper
• Efficacy and safety of antiseizure medication for Lennox–Gastaut syndrome: a systematic review and network meta‐analysis

  2021cites this paper
• Lennox-Gastaut-Syndrom: Wie behandeln?

  2021cites this paper
• Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies

  2021cites this paper
• Clinical Trial Outcome Measurements in Lennox-Gastaut Syndrome and Their Application to the Development of Targeted Treatments

  2021cites this paper
• GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors.

  2021cites this paper
• Pharmacotherapy for Seizures in Tuberous Sclerosis Complex

  2021cites this paper
• A Review of the Selected and Newer Antiseizure Medications Used in Childhood Epilepsies

  2021cites this paper
• Suicidality Risk of Newer Antiseizure Medications: A Meta-analysis.

  2021cites this paper
• Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management

  2021cites this paper
• Current Pharmacologic Strategies for Treatment of Intractable Epilepsy in Children

  2021cites this paper
• Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies

  2021cites this paper
• Rational Antiepileptic Treatment in Childhood

  2021cites this paper
• Antiepileptic Drugs

  2020cites this paper
• Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician

  2020cites this paper
• Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam.

  2020cites this paper
• Improvements in the Pharmacological Profile of Diazepam by KRM-II-81, an Imidazodiazepine Positive Allosteric Modulator of 2/3-Containing GABAA Receptors: Preclinical Data Predict Enhanced Efficacy for Epilepsy, Chronic Pain, Anxiety, and Depression

  2020cites this paper
• Suicidality of Newer Antiseizure Medications: A Meta-Analysis

  2020cites this paper
• Anticonvulsants

  2020cites this paper
• Anticonvulsant Agents: Benzodiazepines (Clobazam, Clonazepam, Diazepam, Lorazepam, Midazolam)

  2020cites this paper
• Rare but life-threatening aspiration pneumonia related to initiation of clobazam therapy

  2020cites this paper
• Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.

  2020cites this paper
• Efficacy and Tolerability of Clobazam in Adults With Drug-Refractory Epilepsy

  2020cites this paper
• Epilepsy—Work-Up and Management in Children

  2020cites this paper
• Safety and effectiveness of surgery for epilepsy in children. Experience of a tertiary hospital in Ecuador

  2019cites this paper
• Physical Health of Adults with Intellectual and Developmental Disabilities

  2019cites this paper
• Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study

  2019cites this paper
• Evaluation of the Effects of Clobazam on Seizure Control and Quality of Life in Children With Lennox-Gastaut Syndrome: A Pilot Study

  2019cites this paper
• Antiepileptic Drug Treatment of Epilepsy in Children

  2019cites this paper
• Don’t Fear the Reefer—Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy

  2019cites this paper
• Safety and Efficacy of Supratherapeutic Doses of Clobazam

  2019cites this paper
• Parasitic pharmacology: A plausible mechanism of action for cannabidiol

  2019cites this paper
• An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome

  2019cites this paper
• Rashes and other hypersensitivity reactions associated with antiepileptic drugs: A review of current literature.

  2019cites this paper
• Pharmacometrics of clobazam in pediatrics: Prediction of effective clobazam doses for Dravet syndrome.

  2019cites this paper
• A reappraisal of atypical absence seizures in children and adults: therapeutic implications

  2019cites this paper
• Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.

  2019cites this paper
• Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions

  2019cites this paper
• Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy

  2018cites this paper
• Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta‐analysis

  2018cites this paper
• Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy

  2018cites this paper
• Safety and effectiveness of surgery for epilepsy in children. Experience of a tertiary hospital in Ecuador.

  2018cites this paper
• Intellectual Disability and Epilepsy

  2018cites this paper
• Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis

  2018cites this paper
• Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community

  2018cites this paper
• Efectividad y seguridad de la cirugía para la epilepsia en niños. Experiencia de un hospital terciario en Ecuador

  2018cites this paper
• Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.

  2018cites this paper
• Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

  2018cites this paper
• Pharmacokinetics of clobazam oral soluble film

  2018cites this paper
• A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam

  2018cites this paper
• Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis

  2018cites this paper
• The pharmacological management of Lennox-Gastaut syndrome and critical literature review.

  2018cites this paper
• Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.

  2018cites this paper
• Overview of Seizure and Epilepsy Syndromes and Their Multidisciplinary Management

  2018cites this paper
• Levetiracetam and Rufinamide are effective at supressing spike and wave seizure activity in an in vitro model of absence epilepsy

  2018cites this paper